1.
Quantitative SSTR-PET/CT for Predicting Response and Survival Outcomes in Patients with Pancreatic Neuroendocrine Tumors Receiving CAPTEM. Radiol Oncol [Internet]. 2023 Nov. 27 [cited 2026 Nov. 20];57(4):436-45. Available from: https://radioloncol.com/index.php/ro/article/view/4118